Paradoxical trafficking and regulation of 5-HT2A receptors by agonists and antagonists

Brain Research Bulletin

Volumn 56, Issue 5, 2001, Pages 441-451

  Gray, John A ^a   Roth, Bryan L ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antidepressant; Antipsychotic; Arrestin; Clozapine; Down regulation; Internalization

Indexed keywords

2 CHLORO 11 (3 DIMETHYLAMINOPROPYLIDENE)MORPHANTHRIDINE; 2,3,3A,12B TETRAHYDRO 3 METHYL 1H DIBENZO[B,F]OXEPINO[10,11 C]PYRROLE; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; AMFEBUTAMONE; AMITRIPTYLINE; AMOXAPINE; ANTIDEPRESSANT AGENT; CHLORPROMAZINE; CITALOPRAM; CLOMIPRAMINE; CLOZAPINE; DESIPRAMINE; DOSULEPIN; FLUOXETINE; GUANINE NUCLEOTIDE BINDING PROTEIN; HALOPERIDOL; IMIPRAMINE; IPRINDOLE; KETANSERIN; LOXAPINE; LYSERGIDE; MIANSERIN; MOPERONE; NEFAZODONE; NEUROLEPTIC AGENT; PARGYLINE; PAROXETINE; PHENELZINE; QUIPAZINE; RISPERIDONE; SEROTONIN 2A RECEPTOR; SPIPERONE; TRANYLCYPROMINE; UNINDEXED DRUG; ZIMELDINE;

ANXIETY NEUROSIS; CONFERENCE PAPER; DEPRESSION; GUINEA PIG; MOOD; NONHUMAN; PERCEPTION; PHYSIOLOGY; PRIORITY JOURNAL; RABBIT; RECEPTOR DOWN REGULATION; SCHIZOPHRENIA; SMOOTH MUSCLE CONTRACTION; THROMBOCYTE AGGREGATION;

ANIMALS; CENTRAL NERVOUS SYSTEM; DOWN-REGULATION; GTP-BINDING PROTEINS; HUMANS; PROTEIN TRANSPORT; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 0035891883     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(01)00623-2     Document Type: Conference Paper

References (108)

1. Paradoxical increase of 5-hydroxytryptamine2 receptors and 5-hydroxytryptamine2 receptor mRNA in cerebellar granule cells after persistent 5-hydroxytryptamine2 receptor stimulation
2. Differential effect of subchronic treatment with various neuroleptic agents on serotonin2 receptors in rat cerebral cortex
3. Effects of selective serotonin reuptake inhibitors on platelet serotonin parameters in major depressive disorder
4. Adrenergic and serotonergic receptor binding in rat brain after chronic desmethylimipramine treatment
5. Rapid agonist-induced internalization of the 5-hydroxytryptamine2A receptor occurs via the endosome pathway in vitro
6. The dynamin-dependent, arrestin-independent internalization of 5-HT2A serotonin receptors reveals differential sorting of arrestins and 5-HT2A receptors during endocytosis
7. Acute and chronic effects of serotonin (5HT) antagonists on serotonin binding sites
8. Serotonin receptor sensitivity after acute and chronic treatment with mianserin
9. Daily LSD administration selectively decreases serotonin2 receptor binding in rat brain
10. Serotonin2 agonist administration down-regulates rat brain serotonin2 receptors
11. The effects of clozapine and haloperidol on serotonin-1A, -2A and -2C receptor gene expression and serotonin metabolism in the rat forebrain
12. The effect of chronic imipramine administration on the densities of 5-HT1A and 5-HT2 receptors and the abundances of 5-HT receptor and transporter mRNA in the cortex, hippocampus and dorsal raphe of three strains of rat
13. Chronic electroconvulsive seizures increase the expression of serotonin2 receptor mRNA in rat frontal cortex
14. Imipramine and tetrabenazine: Effects on monoamine receptor binding sites and phosphoinositide hydrolysis
15. Evidence that chronic administration of paroxetine or fluoxetine enhances 5-HT2 receptor function in the brain of the guinea pig
16. Role of second messengers in agonist up-regulation of 5-HT2A (5-HT2) receptor binding sites in cerebellar granule neurons: Involvement of calcium influx and a calmodulin-dependent pathway
17. Chronic buspirone treatment differentially regulates 5-HT1A and 5-HT2A receptor mRNA and binding sites in various regions of the rat hippocampus
18. G protein-coupled receptors: Heterologous regulation of homologous desensitization and its implications
19. Intact 5HT neuroterminals are not required for 5HT2 receptor down-regulation by amitriptyline
20. Rapid down-regulation of serotonin2 receptor binding during combined administration of tricyclic antidepressant drugs and alpha 2 antagonists
21. Effects of chronic oral administration of the antidepressants, desmethylimipramine and zimelidine on rat cortical GABAB binding sites: A comparison with 5-HT2 binding site changes
22. The 5-HT3B subunit is a major determinant of serotonin-receptor function
23. Decreased 5-HT2 but not 5-HT1 receptor binding in cortex of rat after chronic administration of dothiepin. Application of the Woolf plot to analysis of binding parameters
24. Creation of a constitutively activated state of the 5-hydroxytryptamine2A receptor by site-directed mutagenesis: Inverse agonist activity of antipsychotic drugs
25. G-protein-coupled receptor regulation: Role of G-protein-coupled receptor kinases and arrestins
26. Role of beta-arrestin in mediating agonist-promoted G protein-coupled receptor internalization
27. G-protein-coupled receptor kinases and arrestins: Regulators of G-protein-coupled receptor sequestration
28. Molecular mechanisms of G protein-coupled receptor desensitization and resensitization
29. Bupropion: A new antidepressant drug; the mechanism of action of which is not associated with down-regulation of postsynaptic beta-adrenergic, serotonergic (5-HT2), alpha 2-adrenergic, imipramine and dopaminergic receptors in brain
30. Regulation of 5-HT2A receptor mRNA in P11 cells
31. Regulation of mRNA encoding 5-HT2A receptors in P11 cells through a post-transcriptional mechanism requiring activation of protein kinase C
32. Effects of agonists, partial agonists, and antagonists on the regulation of 5-hydroxytryptamine2 receptors in P11 cells
33. Desensitization of G protein-coupled receptors
34. Role of clathrin-mediated endocytosis in agonist-induced down-regulation of the beta2-adrenergic receptor
35. Comparison of iprindole, imipramine and mianserin action on brain serotonergic and beta adrenergic receptors
36. Different effects of serotonin antagonists on 3H-mianserin and 3H-ketanserin recognition sites
37. Structure and function of the third intracellular loop of the 5-hydroxytryptamine2A receptor: The third intracellular loop is alpha-helical and binds purified arrestins
38. Arrestin/clathrin interaction. Localization of the arrestin binding locus to the clathrin terminal domain
39. Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor
40. 5-Hydroxytryptamine2 and beta-adrenergic receptor regulation in rat brain following chronic treatment with desipramine and fluoxetine alone and in combination
41. Comparisons of the actions of high and low doses of the MAO inhibitor tranylcypromine on 5-HT2 binding sites in rat cortex
42. Cell-type specific effects of endocytosis inhibitors on 5-HT2A receptor desensitization and resensitization reveal an arrestin-, GRK2-, and GRK5-independent mode of regulation in HEK-293 cells
43. Regulation of serotonin2A receptors in heterologous expression systems
44. Unusual acute effects of antidepressants and neuroleptics on S2-serotonergic receptors
45. Desensitization and down-regulation of 5-HT2 receptors in P11 cells
46. 5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: Possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites
47. Beta(2)-adrenergic receptor down-regulation. Evidence for a pathway that does not require endocytosis
48. Serotonin-induced acute desensitization of serotonin2 receptors in human platelets via a mechanism involving protein kinase C
49. Homologous desensitization of serotonin 5-HT2 receptor-stimulated intracellular calcium mobilization in C6BU-1 glioma cells via a mechanism involving a calmodulin pathway
50. Visualization of agonist-induced sequestration and down-regulation of a green fluorescent protein-tagged beta2-adrenergic receptor
51. Differential effects of electroconvulsive shock and antidepressant drugs on serotonin-2 receptors in rat brain
52. Effects of repeated treatment with fluoxetine and citalopram, 5-HT uptake inhibitors, on 5-HT1A and 5-HT2 receptors in the rat brain
53. Visualization of time-dependent redistribution of delta-opioid receptors in neuronal cells during prolonged agonist exposure
54. Endocytosis and recycling of G protein-coupled receptors
55. Effects of antidepressant drug combinations on cortical 5-HT2 receptors and wet-dog shakes in rats
56. The molecular biology of serotonin receptors: Therapeutic implications for the interface of mood and psychosis
57. Arrestin/clathrin interaction. Localization of the clathrin binding domain of nonvisual arrestins to the carboxy terminus
58. Changes in 5-HT2 receptor density induced by repeated treatment with 5-HT uptake inhibitor or 5-HT agonist
59. Differential regulation of rat 5-HT2A and 5-HT2C receptors after chronic treatment with clozapine, chlorpromazine and three putative atypical antipsychotic drugs
60. The interaction of beta-arrestin with the AP-2 adaptor is required for the clustering of beta 2-adrenergic receptor into clathrin-coated pits
61. Down-regulation of opiate receptor in neuroblastoma x glioma NG108-15 hybrid cells. Chloroquine promotes accumulation of tritiated enkephalin in the lysosomes
62. Gaps and peculiarities in 5-HT2 receptor studies
63. Rapid desensitization and down-regulation of 5-HT2 receptors by DOM treatment
64. 5-HT2 receptors, roles and regulation
65. Down regulation of serotonin-S2 receptor sites in rat brain by chronic treatment with the serotonin-S2 antagonists: Ritanserin and setoperone
66. Beta-Arrestin: A protein that regulates beta-adrenergic receptor function
67. Differential effects of antidepressant treatment on brain monoaminergic receptors
68. Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel
69. Effect of typical and atypical antipsychotic drugs on 5-HT2 receptor density in rat cerebral cortex
70. Binding and function of serotonin 2 receptors following chronic administration of imipramine
71. Chronic treatment with (+/-)DOI, a psychotomimetic 5-HT2 agonist, downregulates 5-HT2 receptors in rat brain
72. Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values
73. Synergistic regulation of beta2-adrenergic receptor sequestration: Intracellular complement of beta-adrenergic receptor kinase and beta-arrestin determine kinetics of internalization
74. Epidermal growth factor (EGF)-induced up-regulation and agonist- and antagonist-induced desensitization and internalization of A1 adenosine receptors in a pituitary-derived cell line
75. Rapid desensitization and resensitization of 5-HT2 receptor mediated phosphatidyl inositol hydrolysis by serotonin agonists in quiescent calf aortic smooth muscle cells
76. Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding
77. Regulation of serotonin2 (5-HT2) receptors labeled with [3H]spiroperidol by chronic treatment with the antidepressant amitriptyline
78. Agonist and antagonist-dependent internalization of the human vasopressin V2 receptor
79. Regulation of 5-HT2 receptors in rat cortex. Studies with a putative selective agonist and an antagonist
80. Possible role of protein kinase C in regulation of 5-hydroxytryptamine 2A receptors in rat brain
81. Loss of cortical serotonin2A signal transduction in senescent rats: Reversal following inhibition of protein kinase C
82. Chronic clozapine treatment of rats down-regulates cortical 5-HT2 receptors
83. Antagonist-stimulated internalization of the G protein-coupled cholecystokinin receptor
84. Serotonin 5-HT2A receptors: Molecular biology and mechanisms of regulation
85. Chronic mianserin treatment decreases 5-HT2 receptor binding without altering 5-HT2 receptor mRNA levels
86. Regulation of 5-HT2 and 5-HT1C serotonin receptor levels. Methodology and mechanisms
87. The multiplicity of serotonin receptors: Uselessly diverse molecules or an embarrasment of riches?
88. 5-Hydroxytryptamine2 receptors coupled to phospholipase C in rat aorta: Modulation of phosphoinositide turnover by phorbol ester
89. 5-Hydroxytryptamine2A (5-HT2A) receptor desensitization can occur without down-regulation
90. 5-Hydroxytryptamine2-family receptors (5-hydroxytryptamine2A, 5-hydroxytryptamine2B, 5-hydroxytryptamine2C): Where structure meets function
91. G protein-coupled receptor (GPCR) trafficking in the central nervous system: Relevance for drugs of abuse
92. Selective regulation of Gq signaling by G protein-coupled receptor kinase 2: Direct interaction of kinase N terminus with activated galphaq
93. Decrease in [3H]-serotonin binding in rat brain produced by the repeated administration of either monoamine oxidase inhibitors or centrally acting serotonin agonists
94. Monoamine oxidase inhibitors and serotonin uptake inhibitors: Differential effects on [3H]serotonin binding sites in rat brain
95. Species dependence of adaptations at the pre- and postsynaptic serotonergic receptors following long-term antidepressant drug treatment
96. Down-regulation of serotonin2, but not of beta-adrenergic receptors during chronic treatment with amitryptiline is independent of stimulation of serotonin2 and beta-adrenergic receptors
97. In vivo regulation of the serotonin-2 receptor in rat brain
98. Effect of chronic antidepressant treatment and subsequent withdrawal on [3H]-5-hydroxytryptamine and [3H]-spiperone binding in rat frontal cortex and serotonin receptor mediated behaviour
99. Selective down-regulation of the agonist-dependent high affinity state of rat cortical 5-HT2 receptors following chronic treatment with amperozide
100. Treatment with trazodone plus phenoxybenzamine accelerates development of decreased type 2 serotonin binding in rat cortex
101. Transcriptional regulation of the 5-HT2A receptor
102. Antagonist-mediated down-regulation of 5-hydroxytryptamine type 2 receptor gene expression: Modulation of transcription
103. Downregulation of G protein-coupled receptors
104. Distinct mechanisms regulate 5-HT2 and thrombin receptor desensitization
105. Serotonergic antagonist effects on trafficking of serotonin 5-HT2A receptors in vitro and in vivo
106. Clozapine and other 5-hydroxytryptamine-2A receptor antagonists alter the subcellular distribution of 5-hydroxytryptamine-2A receptors in vitro and in vivo
107. Serotonin 5-HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex
108. A central role for beta-arrestins and clathrin-coated vesicle-mediated endocytosis in beta2-adrenergic receptor resensitization. Differential regulation of receptor resensitization in two distinct cell types